Bipartisan Policy Center Hosts Discussion with Policy Leaders
Thursday, June 23, 2016
9:00 a.m. – 11:00 a.m. ET
Join the webcast.
Join the conversation on Twitter: #BPClive
Please join BPC, along with policy, scientific, industry, and patient leaders, for a discussion on the latest advancements in medical innovation legislation, as well as the release of new recommendations on the importance of using real world evidence to support finding safe and effective cures for Americans.
Today, emerging therapies offer promising cures for life-threatening diseases such as Alzheimer’s, cancer, Parkinson’s, etc. Pending legislation in Congress could streamline getting treatments and cures to patients. It will also bolster both the Food and Drug Administration and the National Institutes of Health to effectively carry out their roles in this charge. The vast increase in available data from electronic health records, claims systems, registries, and even patients themselves, also known as real world evidence, offers an opportunity to change the paradigm of evidence development for treatments in the U.S. Be our guest as we explore these topics.
A conversation with:
- Sen. Lamar Alexander (R-TN) – Chairman, Senate Health, Education, Labor and Pensions Committee
- William H. Frist, MD – Former Senate Majority Leader, Chair, BPC Advancing Medical Innovation
- Doug Oliver – Patient
Panel discussions with:
- Marc Boutin, JD – CEO, National Health Council
- Andrew von Eschenbach, MD – President, Samaritan Health Initiatives, Former FDA Commissioner
- Adrian Hernandez, MD, MHS – Director, Duke Clinical Research Institute
- David Madigan, PhD – Executive Vice President and Dean, Faculty of Arts and Sciences, Columbia University
- Marcus D. Wilson – President, HealthCore, Subsidiary of Anthem, Inc.
- Janet Marchibroda – Director of Health Innovation, BPC
Closing remarks by: Ted Giovanis – President, The Jayne Koskinas Ted Giovanis Foundation for Health and Policy